mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.7 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.7 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.7 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |